Mark Edinger
Mark joined Cytek Biosciences in January 2021 and serves as the company’s VP of Scientific Affairs. As the VP of Scientific Affairs, Mark fills the role of Scientific Advisor and Strategist of Cytek Biosciences. Prior to Cytek, Mark served as the Director of Scientific Affairs at Q2 Solutions, where he placed quantitative standardization of flow cytometers, along with other state of the art practices including the deployment of Cytek Aurora instruments in eight Q2 laboratories around the world. Prior to Q2 Solutions, he served as a Senior Scientist at Becton Dickinson, where he founded the Technical Applications Group and the R&D Systems Verification Laboratory.
Mark began his flow cytometry career at the Cleveland Clinic where he pioneered flow cytometry there in the late 1970’s. During his 21 years there he developed many of the techniques and assays employed today for clinical practice and academic research.
Mark received a BS in Biology from Case Western Reserve University. He holds a MT-ASCP-I certification.